crea plus, crep2, lact2, lactate, glu, trigl/tg, triggb, trig/gb, chol/chol2, hdl-c plus 3rd generation/hdlc3, ldl_c plus 2nd generation/ldl_c, ua2/ua plus 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Roche 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-05-05
  • 사례 출판 날짜
    2015-05-05
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: roche crea plus, crep2, lact2, lactate, glu, trigl/tg, triggb, trig/gb, chol/chol2, hdl-c plus 3rd generation/hdlc3, ldl_c plus 2nd generation/ldl_c, ua2/ua plus medical device manufacturer, roche, has issued a medical device safety alert concerning all lot numbers of crea plus, crep2, lact2, lactate, glu, trigl/tg, triggb, trig/gb, chol/chol2, hdl-c plus 3rd generation/hdlc3, ldl_c plus 2nd generation/ldl_c, ua2/ua plus. the manufacturer has received complaints about falsely low crea plus results for patients with a toxic level of acetaminophen under treatment with n-acetylcysteine (nac). the manufacturer has received complaints about falsely low crea plus results for patients with a toxic level of acetaminophen under treatment with n-acetylcysteine (nac). the manufacturer’s investigations suggest that the peroxidase reaction is interfered with by certain drugs, causing falsely low recovery. the manufacturer advises user to be aware that: the recovery of trinder tests may be falsely low when the blood sample is taken while levels of nac, napqi, and metamizole are still present. venipuncture should be performed prior to the administration of metamizole. venipuncture immediately after or during the administration of metamizole may lead to falsely low results. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 5 may 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: [5 May 2015] Roche CREA plus, CREP2, LACT2, Lactate, GLU, TRIGL/TG, TRIGGB, TRIG/GB, CHOL/CHOL2, HDL-C plus 3rd generation/HDLC3, LDL_C plus 2nd generation/LDL_C, UA2/UA plus
  • Manufacturer

Manufacturer